Trials / Sponsors / David Peereboom
David Peereboom
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence Recurrent Glioblastoma | Phase 2 | 2020-03-19 |
| Active Not Recruiting | Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM Glioblastoma | Phase 2 | 2018-05-21 |
| Completed | Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multifor CNS Tumor, Adult | Phase 2 | 2005-10-01 |